HBM Bioventures

Type: Company

Name: HBM Bioventures (HBM BioVentures Ltd)

Fact Sheet: Fact Sheet for HBM BioVentures Ltd

First Reported 11/02/2009 - Updated 11/02/2009 - 2 Documents (in Health)

Probiodrug gains $54M to back Alzheimer's program

The early-stage German biotech Probiodrug AG won an impressive $54 million in fresh venture capital backing in one of the largest biotech rounds reported this year. The second round was led by BB Biotech and Edmond de Rothschild Investment Partners with ... [FierceBiotech - 11/02/2009]

Entities: Alzheimer's Disease, BB Biotech AG, Biotechnology, TVM Capital GmbH, HBM Bioventures

First Reported 10/19/2009 - Updated 10/20/2009 - 5 Documents (in Corporate Deals)

Lux Biosciences sees $50m in venture capital

Lux Biosciences Inc, a biotech company focused on the development and commercialisation of therapies for ophthalmic diseases, has closed a $50m series B venture financing. Participants in the funding were current investors in Lux Biosciences, HBM Bioventures, ... [AltAssets.net - 10/20/2009]

Entities: Lux Biosciences Inc, Venture Capital, Private Equity

First Reported 10/19/2009 - Updated 10/19/2009 - 1 Documents

Lux Biosciences Completes $50 Million Series B Financing

Lux Biosciences, Inc., a privately held biotechnology company focused on the development and commercialization of therapies for serious ophthalmic diseases, today announced that the company has closed a $50 million Series B venture financing. Participants ... [Individual.com - 10/19/2009]

Entities: Lux Biosciences Inc, Complementary, International Biotechnology Trust, Prospect Venture Partners, HBM Bioventures

More Content

sort by: Date \| Relevance
Zosano Pharma, Inc. Announces Publication of Po... [Pharmacy Choice - 11/09/2009]
Probiodrug AG Closes Series B Financing Round E... [BioSpace - 11/02/2009]
Probiodrug gains $54M to back Alzheimer's program [FierceBiotech - 11/02/2009]
Zosano Pharma, Inc. to Provide Pipeline Updates... [Business Wire - 11/02/2009]
Alzheimers treatment developer Probiodrug raises [AltAssets.net - 11/02/2009]
Venture Capital Flows to Biotech as Public Fina... [Seeking Alpha - 10/25/2009]
Lux Biosciences sees $50m in venture capital [AltAssets.net - 10/20/2009]
Lux Biosciences Raises $50 Million [Private Equity HUB - 10/20/2009]
Lux Biosciences scores $50M Series B for eye cure [Venturebeat - 10/20/2009]
Lux Biosciences raises $50 million in Series B ... [Individual.com - 10/19/2009]
Lux Biosciences scores $50M Series B for eye cure [Industry Standard - 10/19/2009]
Emerging Drug Developer: Lux Biosciences [FierceBiotech - 10/19/2009]
Lux Biosciences raises $50 million through Seri... [News-Medical.Net - 10/19/2009]
Lux Biosciences Completes $50 Million Series B ... [Individual.com - 10/19/2009]

Blogs

sort by: Date \| Relevance
Venture Capital Flows to Biotech as Public Fina... [Biotech Sector and Stocks Analysis from Seeking ... - 10/25/2009] The Burrill Report submits: by MARIE DAGHLIANFollowing a week of little activity, venture financing for life science companies got hot. Even General Electric (GE) ...
Lux Biosciences scores $50M Series B for eye cure [Venturebeat - 10/19/2009] In what is possibly the largest biotech investment round to date, Lux Biosciences has obtained another $50 million from its existing investors. HBM Bioventures, ...

Change Password

Products & Services
Silobreaker.com
Enterprise Online Service
Enterprise Software Suite
Widgets & API

How To Use
Silobreaker
RSS
API
Widgets

Advertise With Us
Advertise

Follow Us
Press Room
Blog
YouTube
Twitter

About Us
About Silobreaker
Background and History
Why Silobreaker?
Value Proposition
Technology
Team
Contact Us

Legal
Terms of Use
Privacy Policy

Log in to Silobreaker

Advanced Search Options

HBM Bioventures